Bears Pile In: Biotech & Prison Stocks Spike
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Short sellers made fresh moves this week across biotech and an unlikely corner of the market — private prison operators.
REPL (Replimune Group) saw its short interest jump to 43.3% of free float, up nearly 11 percentage points in seven days. The biotech stock has surged 188% over three months. Bears are clearly betting the rally won't last.
TNGX (Tango Therapeutics) sits at a hefty 64.5% SI % FF, up almost 8 points in a week. Shares have barely moved in three months, yet short pressure keeps building. Cost to borrow is still low at 0.55%, meaning more shorting capacity remains.
The week's most surprising mover was CXW (CoreCivic). Its short interest shot from just 2.3% to 10.3% FF in seven days — a 340% relative increase. The private prison operator rarely attracts this level of short attention.
HTZ (Hertz) remains a market favourite for bears. SI sits at 69.2% FF, with a punishing cost-to-borrow of 7.7%. The stock has fallen 53% in three months.
LCID (Lucid Group) carries the highest borrowing cost at 31.7% APR — shorting it is expensive. EVCM (EverCommerce) isn't far behind at 39.7% APR, carrying the top ORTEX short score at 93.9 out of 100.
Meanwhile, CHWY (Chewy) shorts covered aggressively. SI dropped 20 points to 94.3% FF, suggesting some bears are retreating.
This note is for informational purposes only and does not constitute financial advice.
Stocks in this article
How this article was generated
- Generated
- 13 Aug 2026, 12:03
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilization
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.